Literature DB >> 25220977

Adiponectin and insulin cross talk: the microvascular connection.

Lina Zhao1, Zhuo Fu1, Zhenqi Liu2.   

Abstract

Adiponectin exerts both vasodilatory and insulin-sensitizing actions and its levels are decreased in insulin-resistant humans and animals. The mechanisms underlying adiponectin׳s insulin-sensitizing effect have been extensively investigated but remain largely unclear. Muscle microvasculature critically regulates muscle insulin action by modulating insulin delivery to the microvessels nurturing the muscle cells and the trans-endothelial insulin transport. We have recently reported that adiponectin exerts its insulin-sensitizing effect via recruiting muscle microvasculature, expanding the endothelial surface area, and increasing insulin delivery to and thus action in muscle. The current review focuses on the microvascular connection between the adiponectin and insulin cross talk.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220977      PMCID: PMC4252703          DOI: 10.1016/j.tcm.2014.08.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  78 in total

1.  Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature.

Authors:  Zhenqi Liu; Jia Liu; Linda A Jahn; Dale E Fowler; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 2.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 3.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.

Authors:  E J Barrett; E M Eggleston; A C Inyard; H Wang; G Li; W Chai; Z Liu
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

4.  Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.

Authors:  Lucy H Clerk; Michelle A Vincent; Eugene J Barrett; Miles F Lankford; Jonathan R Lindner
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

5.  AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.

Authors:  Zhen Chen; I-Chen Peng; Wei Sun; Mei-I Su; Pang-Hung Hsu; Yi Fu; Yi Zhu; Kathryn DeFea; Songqin Pan; Ming-Daw Tsai; John Y-J Shyy
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

6.  Insulin signaling stimulates insulin transport by bovine aortic endothelial cells.

Authors:  Hong Wang; Aileen X Wang; Zhenqi Liu; Eugene J Barrett
Journal:  Diabetes       Date:  2007-10-31       Impact factor: 9.461

7.  APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice.

Authors:  Kenneth K Y Cheng; Miguel A Iglesias; Karen S L Lam; Yu Wang; Gary Sweeney; Weidong Zhu; Paul M Vanhoutte; Edward W Kraegen; Aimin Xu
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

8.  Endothelial dysfunction in adiponectin deficiency and its mechanisms involved.

Authors:  Yu Cao; Ling Tao; Yuexing Yuan; Xiangying Jiao; Wayne Bond Lau; Yajing Wang; Theodore Christopher; Bernard Lopez; Lawrence Chan; Barry Goldstein; Xin L Ma
Journal:  J Mol Cell Cardiol       Date:  2008-11-05       Impact factor: 5.000

9.  Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.

Authors:  April C Inyard; Daniel G Chong; Alexander L Klibanov; Eugene J Barrett
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

Review 10.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more
  9 in total

1.  Effect of Serum Adiponectin Levels on the Association Between Childhood Body Mass Index and Adulthood Carotid Intima-Media Thickness.

Authors:  Yang Du; Tao Zhang; Dianjianyi Sun; Changwei Li; Lydia Bazzano; Lu Qi; Marie Krousel-Wood; Jiang He; Paul K Whelton; Wei Chen; Shengxu Li
Journal:  Am J Cardiol       Date:  2017-12-12       Impact factor: 2.778

Review 2.  Vascular function, insulin action, and exercise: an intricate interplay.

Authors:  Chao Zheng; Zhenqi Liu
Journal:  Trends Endocrinol Metab       Date:  2015-02-23       Impact factor: 12.015

3.  Intrinsic disorder in biomarkers of insulin resistance, hypoadiponectinemia, and endothelial dysfunction among the type 2 diabetic patients.

Authors:  Osama H Al-Jiffri; Fadwa M Al-Sharif; Essam H Al-Jiffri; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-05-11

Review 4.  Space Flight-Promoted Insulin Resistance as a Possible Disruptor of Wound Healing.

Authors:  F Strollo; S Gentile; A M V Pipicelli; A Mambro; M Monici; P Magni
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 5.  Adipocytokines and hepatic fibrosis.

Authors:  Neeraj K Saxena; Frank A Anania
Journal:  Trends Endocrinol Metab       Date:  2015-02-02       Impact factor: 12.015

6.  A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes.

Authors:  Zhihua Du; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2017-09-21       Impact factor: 5.923

Review 7.  Adiponectin as a novel biomarker for liver fibrosis.

Authors:  Wanvisa Udomsinprasert; Sittisak Honsawek; Yong Poovorawan
Journal:  World J Hepatol       Date:  2018-10-27

8.  Impact of weight reduction on insulin resistance, adhesive molecules and adipokines dysregulation among obese type 2 diabetic patients.

Authors:  Shehab M Abd El-Kader; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

Review 9.  Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease.

Authors:  Angelo Armandi; Chiara Rosso; Gian Paolo Caviglia; Elisabetta Bugianesi
Journal:  Metabolites       Date:  2021-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.